The Specialty Pharmacy Review Board - Assessing the Evolving Value of Rheumatoid Arthritis Therapies
Satellite Breakfast Symposium
The Specialty Pharmacy Review BoardTM - Assessing the Evolving Value of Rheumatoid Arthritis Therapies


Jointly provided by Medical Education Resources, Inc. and Impact Education, LLC.
Impact Education, LLC     Medical Education Resources, Inc.
This activity is supported by an independent educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.LillyGrantOffice.com.
Thursday, March 30, 2017
6:00 AM - 7:45 AM
Colorado Convention Center
Room Mile High 1A-1C
Denver, CO


Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 is required.
Held in conjunction with

AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017.


Click here to download the slides from this symposium.
  HOT TOPICS
  • Clinical benefits of RA therapies in a managed care setting
  • Decision support tools to enhance medical and pharmacy benefit design decision-making for patients with RA
  • Specialty pharmacy and disease management services that can improve the quality of care
  DISTINGUISHED FACULTY PRESENTERS
Steven G. Avey, MS, RPh, FAMCP
Vice President, Specialty Pharmacy Programs
MedImpact Healthcare Systems, Inc.
Robin Dore, MD
Clinical Professor of Medicine
David Geffen School of Medicine
UCLA
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsulting
Fadia Tohme-Shaya, PhD, MPH
Professor and Vice Chair for Academic Affairs
University of Maryland School of Pharmacy
  WHO SHOULD ATTEND?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017.

  STATEMENT OF NEED / PROGRAM OVERVIEW

There is no cure for rheumatoid arthritis (RA), but new effective drugs are increasingly available to treat the disease and prevent deformed joints. Currently, the RA therapeutic pipeline is robust and includes agents that utilize novel mechanisms of action (MOAs) and various administration strategies (eg, oral, subcutaneous injection).

The educational format of The Specialty Pharmacy Review BoardTM will feature a multi-specialty, multi-professional faculty that collaborate, under the leadership of an Activity Chair, on the review of the clinical data, current guidelines, and economic data of a class of therapeutics. Similar to a mock pharmacy and therapeutics committee format, the program will include time for peer-to-peer discussion and debate among the diverse group of faculty members and the audience.

  EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Assess decision support tools to enhance medical and pharmacy benefit design decision-making for patients with RA
  • Interpret results of decision support tools with health plan affiliated rheumatology professionals to improve outcomes for patients with RA
  • Employ specialty pharmacy and disease management services that can improve the quality of care for patients with RA
  • Provide accurate and appropriate counsel as part of the managed care treatment team
  AGENDA

Date and Time
Thursday, March 30, 2017
6:00 AM - 7:45 AM
Colorado Convention Center
Room Mile High 1A-1C
Denver, CO

6:00 AM Breakfast and Registration
6:05 AM Pre-Activity Learning Assessment and Opening Comments
Edmund Pezalla, MD, MPH
6:10 AM Clinical Benefits Overview - Assessing the Clinical Benefits of RA Therapies in a Managed Care Setting
Robin Dore, MD
6:35 AM Practice Guidelines Review - Current Practice Guidelines Review
Edmund Pezalla, MD, MPH
6:55 AM Health Economics and Pharmacoeconomics Assessment - Analyzing the Available Data to Assess the Value of Treatment Options
Fadia Tohme-Shaya, PhD, MPH
7:15 AM Comparator Treatment Analysis - Comparative Analyses for Evidence- Based Treatment and Benefit Design Decision Making

Benefit Design and Specialty Pharmacy Management Services - Maximizing Value for Current and Emerging RA Therapies
Steven G. Avey, MS, RPh, FAMCP
7:35 AM Audience Question and Answer Session
Closing Commentary
Post-Test Assessment

7:45 AM Adjournment
  ACCREDITATION INFORMATION
Physician Continuing Medical Education
Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education
Accreditation Statement
Medical Education Resources, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Medical Education Resources, Inc. designates this continuing education activity for 1.75 contact hours (0.175 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - 0816-9999-17-078-L01-P

Type of Activity: Knowledge


Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: No additional fee is required to attend this CPE/CME activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2017 is required.

Pre-registration will close at 12:00 pm on March 29, 2017.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.